---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-21-060919"
form_type: "8-K"
ticker: "ACHV"
cik: "0000949858"
company_name: "ACHIEVE LIFE SCIENCES, INC."
filed_at: "2021-12-22T23:59:59+00:00"
generated_at: "2026-06-27T23:09:07.435068+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Achieve Life Sciences enters $15M contingent convertible debt agreement with SVB

## Summary
- $15M initial term loan from SVB and SVB Innovation Credit Fund VIII; up to $10M additional subject to approval.
- Convertible at $9.34/share; mandatory conversion if stock closes at $24+ for 30 consecutive trading days.
- Interest: floating (prime−1%, floor 2.25%) cash + 7% PIK compounded monthly.
- Maturity Dec 22, 2023, extendable to Dec 22, 2024 upon mutual agreement; prepayment penalties apply.

## SEC filing metadata
- accession: 0001564590-21-060919
- form_type: 8-K
- ticker: ACHV
- cik: 0000949858
- company_name: ACHIEVE LIFE SCIENCES, INC.
- filed_at: 2021-12-22T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/949858/000156459021060919/0001564590-21-060919-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/949858/000156459021060919/achv-8k_20211222.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-21-060919
- JSON: https://secwatch.observer/filing/0001564590-21-060919.json
- Plain text: https://secwatch.observer/filing/0001564590-21-060919.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.